DRTSW · Alpha Tau Medical Ltd. Warrant
View on chartInsiders & Stakes
| Levy Raphi Chief Financial Officer | ▼ Sell | Open Market | 90,180 Shares held | 8/21/2026 | View profile |
Transaction History
| Levy Raphi | ▲ Buy | Option Exercise | 2,871 | $9K | 8/21/2026 |
| Levy Raphi | ▼ Sell | Open Market | 2,871 | $43K | 8/21/2026 |
| Levy Raphi | ▲ Buy | Option Exercise | 17,730 | $53K | 8/11/2026 |
| Levy Raphi | ▼ Sell | Open Market | 17,730 | $248K | 8/11/2026 |
| Levy Raphi | ▲ Buy | Option Exercise | 2,270 | $7K | 7/6/2026 |
| Levy Raphi | ▼ Sell | Open Market | 2,270 | $32K | 7/6/2026 |
| Levy Raphi | ▲ Buy | Option Exercise | 17,873 | $53K | 7/2/2026 |
| Levy Raphi | ▼ Sell | Open Market | 17,873 | $232K | 7/2/2026 |
| Levy Raphi | ▲ Buy | Option Exercise | 2,127 | $6K | 7/1/2026 |
| Levy Raphi | ▼ Sell | Open Market | 2,127 | $28K | 7/1/2026 |
| Levy Raphi | ▼ Sell | Open Market | 20,000 | $240K | 6/30/2026 |
| Levy Raphi | ▼ Sell | Open Market | 4,222 | $46K | 6/25/2026 |
| Levy Raphi | ▼ Sell | Open Market | 15,778 | $174K | 6/25/2026 |
| Levy Raphi | ▼ Sell | Open Market | 15,000 | $142K | 6/23/2026 |
| Levy Raphi | ▼ Sell | Open Market | 2,500 | $25K | 6/23/2026 |
| Levy Raphi | ▼ Sell | Open Market | 17,500 | $191K | 6/3/2026 |
| Levy Raphi | ▼ Sell | Open Market | 15,000 | $161K | 6/3/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Alpha Tau Medical to Join October Investor Conferences
Alpha Tau Medical Ltd. will take part in investor conferences scheduled for October, giving analysts a chance to discuss the company's strategy and outlook. The move follows a mixed social media reaction to market openings, with some stocks gaining early momentum. The company's shares trade near the middle of their 52‑week range, and the current RSI suggests moderate momentum.
Alpha Tau Medical to Join October Investor Conferences. Alpha Tau Medical Ltd. will take part in investor conferences scheduled for October, giving analysts a chance to discuss the company's strategy and outlook. The move follows a mixed social media reaction to market openings, with some stocks gaining early momentum. The company's shares trade near the middle of their 52‑week range, and the current RSI suggests moderate momentum.